Events
5 minute read

MBHB Partner Kevin Noonan a Featured Presenter at ACI's 2nd Advanced Summit on Life Sciences Patents

Kevin E. Noonan, Ph.D.February 23, 20169:30 am - 10:30 am

MBHB partner Dr. Kevin Noonan is a featured presenter at the American Conference Institute’s 2nd Advanced Summit on Life Sciences Patents set for Feb. 23-24, 2016 in New York City.


Details for Dr. Noonan’s presentation are as follows:


Tuesday, February 23 – 9:30-10:30 a.m. ET


The Year of the Biosimilar: Refining Current Life Sciences Patent Strategies and Formulating a Multi-Faceted Approach for Innovators and Biosimilars Manufacturers




  • Analyzing which biologics may be ripe for a biosimilar including monoclonal antibodies, therapeutic proteins, and vaccines going off patent soon


  • Crafting a winning biologic patenting strategy: Devising claim drafting methods for and against biosimilars



    • Strategies to head off biosimilar development


    • Working around narrowly written biopharmaceutical patents


    • Unique challenges for process patents


    • Claiming existing biologics broadly enough to cover biosimilars


  • Analyzing how current IP case law will shape claiming and litigating biosimilars: considerations for the safe harbor, indefiniteness, and natural products


  • Determining what may constitute a “biobetter” and choosing whether to seek pure “biosimilarity” or an improved “biobetters” product or both


  • Updates on the first BPCIA cases and the opting-in/opting-out debate: Sandoz v. Amgen and Janssen v. Celltrion

 


About American Conference Institute


A unique organization, American Conference Institute is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in the US, and around the world. Staffed by industry specialists, lawyers and other professionals, American Conference Institute operates as a think tank, monitoring trends and developments in all major industry sectors, the law, and public policy, with a view to providing information on the leading edge.


View complete details including registration